Macrogen, Inc. (KOSDAQ:038290)
16,870
-100 (-0.59%)
At close: Dec 30, 2025
Macrogen Market Cap
Macrogen has a market cap or net worth of 182.89 billion as of December 30, 2025. Its market cap has increased by 11.08% in one year.
Market Cap
182.89B
Enterprise Value
259.68B
Revenue
179.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,870.00
Market Cap Chart
Since September 14, 2000, Macrogen's market cap has increased from 148.29B to 182.89B, an increase of 23.34%. That is a compound annual growth rate of 0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 183.98B | 11.87% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.97T |
| Celltrion | 39.67T |
| ALTEOGEN | 24.04T |
| ABL Bio | 10.99T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.44T |
| HLB Co., Ltd. | 6.69T |
| LigaChem Biosciences | 6.36T |